Discovery of LH10, a novel fexaramine-based FXR agonist for the treatment of liver disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Discovery of LH10, a novel fexaramine-based FXR agonist for the treatment of liver disease

Published:2024-02 Issue: Volume:143 Page:107071
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Huang Wanqiu,Cao Zhijun,Wang Wenxin,Yang Zhongcheng,Jiao Shixuan,Chen Ya,Chen Siliang,Zhang Luyong,Li Zheng

Publisher

Elsevier BV

Reference67 articles.

1. Enterohepatic and non-canonical roles of farnesoid X receptor in controlling lipid and glucose metabolism;Zhou;Mol. Cell. Endocrinol.,2022

2. Deciphering the nuclear bile acid receptor FXR paradigm;Modica;Nucl. Recept. Signal.,2010

3. Farnesoid X receptor responds to bile acids and represses cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription;Chiang;J. Biol. Chem.,2000

4. Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration;Li;Acta Pharm. Sin. B,2015

5. FXR in liver physiology: Multiple faces to regulate liver metabolism;Panzitt;Biochim Biophys Acta Mol Basis Dis,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunology of bile acids regulated receptors;Progress in Lipid Research;2024-07

2. Dysregulated bile acid homeostasis: unveiling its role in metabolic diseases;Medical Review;2024-06-04

3. Tailoring FXR Modulators for Intestinal Specificity: Recent Progress and Insights;Molecules;2024-04-27

4. Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets;Signal Transduction and Targeted Therapy;2024-04-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP